Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
2
×
achromatopsia
beta-thalassemia
bill cassidy
bluebird bio
boston blog main
boston top stories
clinical trials
column
deals
dna
federal trade commission
gene therapy
harvard pilgrim health care
health
healthtech
hemophilia
johnson & johnson
life sciences
luxturna
mark warner
mathai mammen
medicaid
meiragtx
mobile health
national blog main
national top stories
new york
new york blog main
new york top stories
novartis
patient affordability value and efficiency act
spark therapeutics
spinal muscular atrophy
tc
university of pennsylvania
value based agreements
x-linked retinitis pigmentosa
zolgensma
What
come
2
×
age
annual
better
big
bigger
biggest
billion
break
built
collides
culture
dash
deal
emerging
estimated
exploding
fast
faster
gave
gene
great
growing
growth
health
healthtech
hockey
industry
j
johnson
mad
market
media
medicine
meiragtx
mobile
morning
pains
past
personalized
Language
Current search:
come
×
fda
×
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@techcrunch.com
7 years ago
The growing pains of mobile health
